4//SEC Filing
Dhingra Ankur 4
Accession 0001849682-22-000003
CIK 0001599298other
Filed
Jun 1, 8:00 PM ET
Accepted
Jun 2, 5:29 PM ET
Size
5.6 KB
Accession
0001849682-22-000003
Insider Transaction Report
Form 4
Dhingra Ankur
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2022-05-31+600,000→ 600,000 totalExercise: $1.33Exp: 2032-05-31→ Common Stock (600,000 underlying)
Footnotes (2)
- [F1]The option was granted on May 31, 2022. The shares underlying the option are scheduled to vest in four equal annual installments, with the first such installment occurring on May 31, 2023 (the one-year anniversary of the grant date).
- [F2]Not applicable.
Documents
Issuer
Summit Therapeutics Inc.
CIK 0001599298
Entity typeother
Related Parties
1- filerCIK 0001849682
Filing Metadata
- Form type
- 4
- Filed
- Jun 1, 8:00 PM ET
- Accepted
- Jun 2, 5:29 PM ET
- Size
- 5.6 KB